期刊
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
卷 90, 期 5, 页码 830-834出版社
AMER SOC TROP MED & HYGIENE
DOI: 10.4269/ajtmh.13-0678
关键词
-
资金
- 6th National Plan (PN) of Research + Development + Innovation (I+D+I)
- Carlos III Health Institute (ISCIII) General Division Networks
- Cooperative Research Centres + Collaborative Research Network on Tropical Diseases (RICET) [RD12/0018/0020, RD12/0018/0011]
Strongyloides stercoralis infection is being increasingly diagnosed out of endemic areas. The aim of this study is to evaluate the usefulness of S. stercoralis serology for the management of probable strongyloidiasis in patients presenting with eosinophilia. Overall, 147 patients were included, 89 (60.5%) patients had a positive S. stercoralis serology. Strongyloides stercoralis larvae were detected only in 15 (10.2%) patients. Twenty-eight patients had human immunodeficiency virus infection. Eighty patients received ivermectin 200 mcg/Kg/day for 2 days, and follow-up 6 months after treatment could be performed in 32 patients: 26 (81.3%) patients reached the response to treatment criteria (negative serology 6 months after treatment or when by enzyme-linked immunosorbent assay the optical density ratio of post-treatment to pre-treatment decreased to 0.6), and 11 (34.4%) patients fulfilled the cure criteria (negative serology 6 months after treatment). Strongyloides stercoralis serology is a useful diagnostic tool both in the diagnosis of probable strongyloidiasis and follow-up after treatment.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据